Company intelligence / Profile preview
Renova Therapeutics
Carlsbad/San Diego area, California, United Statesrenovatherapeutics.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Renova Therapeutics is advancing a pipeline of one-time gene therapies targeting cardiovascular and metabolic diseases. Its lead candidate RT-100 has shown promising safety and efficacy results in a completed phase 2 clinical trial for heart failure and is moving toward pivotal phase 2b/3 trials. RT-200 has demonstrated positive preclinical results for type 2 diabetes and is being prepared for initial human studies under the UK's ILAP program. Both programs have received Innovation Passport designations from the UK MHRA. The company’s approach aims to provide durable, potentially life-long benefits with single-dose treatments.
- Therapeutic areas
- EndocrinologyCardiovascular
- Modalities
- Gene therapyPeptide therapy
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
03
Partnerships
Previously partnered with NASDAQ Private Market for equity management/liquidity solutions.Licensed stresscopin IND file from Janssen Pharmaceuticals in past years. No major ongoing pharma partnerships disclosed.
04
Financials
- Market cap
- $393.2M
- Total revenue
- $553.9M
- Enterprise value
- $2B
Beyond the preview
Go deeper on Renova Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Renova Therapeutics.